Gapping down
Other news:
- NKLA -9.8% (continued weakness following short report last week)
- MNK -9.2% (receives a Complete Response Letter from the FDA for terlipressin for the treatment of hepatorenal syndrome type 1)
- ZYNE -2.8% (provided update on its Fragile X syndrome and developmental and epileptic encephalopathies programs)
- VXX -0.5% (trading lower with US futures up over 1%)
Analyst comments:
- MGM -1.2% (downgraded to Sell from Neutral at Goldman)
- KR -0.8% (downgraded to Neutral from Buy at BofA Securities)
- TOT -0.8% (downgraded to Neutral from Outperform at Credit Suisse)
- JAZZ -0.6% (downgraded to Sell from Neutral at Goldman)
- CASY -0.5% (downgraded to Underweight from Neutral at JP Morgan)